These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7115627)

  • 1. Antithrombin III transfusion in patients with hepatic cirrhosis.
    Schipper HG; ten Cate JW
    Br J Haematol; 1982 Sep; 52(1):25-33. PubMed ID: 7115627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian rhythms of fibrinogen and antithrombin III in liver cirrhosis.
    Pasqualetti P; Casale R
    Riv Eur Sci Med Farmacol; 1995; 17(4):125-9. PubMed ID: 8545565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turnover study of prothrombin, antithrombin III and fibrinogen in patients with liver cirrhosis.
    Saitoh H; Kobayashi N; Maekawa T
    Nihon Ketsueki Gakkai Zasshi; 1986 Sep; 49(6):1263-74. PubMed ID: 3811789
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of fibrinogen in cirrhosis of the liver.
    Tytgat GN; Collen D; Verstraete M
    J Clin Invest; 1971 Aug; 50(8):1690-701. PubMed ID: 5163179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration.
    Collen D; Schetz J; de Cock F; Holmer E; Verstraete M
    Eur J Clin Invest; 1977 Feb; 7(1):27-35. PubMed ID: 65284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease.
    Scherer R; Kabatnik M; Erhard J; Peters J
    Intensive Care Med; 1997 Nov; 23(11):1150-8. PubMed ID: 9434921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III metabolism in patients with liver disease.
    Knot E; Ten Cate JW; Drijfhout HR; Kahlé LH; Tytgat GN
    J Clin Pathol; 1984 May; 37(5):523-30. PubMed ID: 6725600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of hemostatic balance with antithrombin III replacement therapy in a case of liver cirrhosis associated with recurrent venous thrombosis.
    Carmassi F; Morale M; De Negri F; Carrai M
    J Mol Med (Berl); 1995 Feb; 73(2):89-93. PubMed ID: 7627635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of antithrombin III in cirrhosis and carcinoma of the liver.
    Chan V; Lai CL; Chan TK
    Clin Sci (Lond); 1981 Jun; 60(6):681-8. PubMed ID: 6265140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasma turnover of transfused antithrombin concentrate in patients with acquired antithrombin deficiency.
    Harper PL; Park GR; Carrell RW
    Transfus Med; 1996 Mar; 6(1):45-50. PubMed ID: 8696447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen survival and fibrinopeptide A in acute leukemia.
    Castaman G; Galloni E; Dri AV; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma antithrombin III level in hyperlipidemic subjects.
    Cucuianu MP; Cristea A; Roman S; Missits I
    Clin Chim Acta; 1981 Mar; 110(2-3):147-55. PubMed ID: 7226527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic and antifibrinolytic effects of antithrombin III replacement in liver cirrhosis.
    Carmassi F; De Negri F; Morale M; Ferrini L
    Lancet; 1997 Apr; 349(9058):1069. PubMed ID: 9107249
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombin III metabolism in two colitis patients with acquired antithrombin III deficiency.
    Knot EA; ten Cate JW; Bruin T; Iburg AH; Tytgat GN
    Gastroenterology; 1985 Aug; 89(2):421-5. PubMed ID: 4007429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antithrombin III substitution in patients in shock].
    Vinazzer H; Blauhut B; Bergmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):806-16. PubMed ID: 6083957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased production or increased turnover of antithrombin III in severe acquired coagulopathy?
    Schmidt B; Wais U; Pringsheim W; Witt I; Künzer W
    Klin Wochenschr; 1981 Dec; 59(24):1349-51. PubMed ID: 7321483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian rhythms of fibrinogen antithrombin III and plasminogen in chronic liver diseases of increasing severity.
    Pasqualetti P; Festuccia V; Acitelli P; Natali L; Collacciani A; Casale R
    Haemostasis; 1997; 27(3):140-8. PubMed ID: 9306131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
    Nowak-Göttl U; Groll A; Kreuz WD; Brand M; Breddin HK; von Loewenich V; Kornhuber B
    Klin Padiatr; 1992; 204(3):134-40. PubMed ID: 1614177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
    Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
    Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.